These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 17158942)

  • 1. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
    Zhou J; Chen Y; Tabibi S; Alba L; Garber E; Saiman L
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1085-8. PubMed ID: 17158942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging cystic fibrosis pathogens: incidence and antimicrobial resistance.
    Magni A; Giordano A; Mancini C; Pecoraro C; Varesi P; Quattrucci S; Trancassini M
    New Microbiol; 2007 Jan; 30(1):59-62. PubMed ID: 17319602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burkholderia cepacia complex infection in adult patients with cystic fibrosis--is early eradication possible?
    Etherington C; Peckham DG; Conway SP; Denton M
    J Cyst Fibros; 2003 Dec; 2(4):220-1. PubMed ID: 15463878
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of breakpoint combination sensitivity testing as a simple and convenient method to evaluate the combined effects of ceftazidime and tobramycin on Pseudomonas aeruginosa and Burkholderia cepacia complex isolates in vitro.
    Tunney MM; Scott EM
    J Microbiol Methods; 2004 Apr; 57(1):107-14. PubMed ID: 15003693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonality and Antimicrobial Susceptibility of Burkholderia cepacia complex Isolates Collected from Cystic Fibrosis Patients during 1998-2013 in Bern, Switzerland.
    Lupo A; Isis E; Tinguely R; Endimiani A
    New Microbiol; 2015 Apr; 38(2):281-8. PubMed ID: 25938755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.
    Moriarty TF; McElnay JC; Elborn JS; Tunney MM
    Pediatr Pulmonol; 2007 Nov; 42(11):1008-17. PubMed ID: 17902147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burkholderia cepacia complex infection in a cohort of Italian patients with cystic fibrosis.
    Lambiase A; Raia V; Stefani S; Sepe A; Ferri P; Buonpensiero P; Rossano F; Del Pezzo M
    J Microbiol; 2007 Jun; 45(3):275-9. PubMed ID: 17618236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria.
    Peeters E; Nelis HJ; Coenye T
    J Antimicrob Chemother; 2009 Oct; 64(4):801-9. PubMed ID: 19633000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel antibiotic combinations proposed for treatment of
    El-Halfawy OM; Naguib MM; Valvano MA
    Antimicrob Resist Infect Control; 2017; 6():120. PubMed ID: 29204272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro interactions of tobramycin with various nonantibiotics against Pseudomonas aeruginosa and Burkholderia cenocepacia.
    Treerat P; Widmer F; Middleton PG; Iredell J; George AM
    FEMS Microbiol Lett; 2008 Aug; 285(1):40-50. PubMed ID: 18513356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients.
    Papp-Wallace KM; Becka SA; Zeiser ET; Ohuchi N; Mojica MF; Gatta JA; Falleni M; Tosi D; Borghi E; Winkler ML; Wilson BM; LiPuma JJ; Nukaga M; Bonomo RA
    ACS Infect Dis; 2017 Jul; 3(7):502-511. PubMed ID: 28264560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Burkholderia cepacia complex be eradicated with nebulised amiloride and TOBI?
    Ball R; Brownlee KG; Duff AJ; Denton M; Conway SP; Lee TW
    J Cyst Fibros; 2010 Jan; 9(1):73-4. PubMed ID: 19932062
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of the E test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis.
    Manno G; Ugolotti E; Belli ML; Fenu ML; Romano L; Cruciani M
    Eur J Clin Microbiol Infect Dis; 2003 Jan; 22(1):28-34. PubMed ID: 12582741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of recombinant human lactoferrin on growth and the antibiotic susceptibility of the cystic fibrosis pathogen Burkholderia cepacia complex when cultured planktonically or as biofilms.
    Caraher EM; Gumulapurapu K; Taggart CC; Murphy P; McClean S; Callaghan M
    J Antimicrob Chemother; 2007 Sep; 60(3):546-54. PubMed ID: 17595284
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Mazer DM; Young C; Kalikin LM; Spilker T; LiPuma JJ
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant
    Zeiser ET; Becka SA; Wilson BM; Barnes MD; LiPuma JJ; Papp-Wallace KM
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia.
    Aaron SD; Ferris W; Henry DA; Speert DP; Macdonald NE
    Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1206-12. PubMed ID: 10764313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis.
    Kitt H; Lenney W; Gilchrist FJ
    BMC Pharmacol Toxicol; 2016 Mar; 17():14. PubMed ID: 27018049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis.
    Saiman L; Chen Y; Tabibi S; San Gabriel P; Zhou J; Liu Z; Lai L; Whittier S
    J Clin Microbiol; 2001 Nov; 39(11):3942-5. PubMed ID: 11682511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity and synergy of bismuth thiols and tobramycin against Burkholderia cepacia complex.
    Veloira WG; Domenico P; LiPuma JJ; Davis JM; Gurzenda E; Kazzaz JA
    J Antimicrob Chemother; 2003 Dec; 52(6):915-9. PubMed ID: 14585856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.